梗阻性结肠癌内镜下支架置入作为手术桥接后的十年生存率
这项前瞻性研究纳入1998至2013年间比利时一家医院97例梗阻性但可能可治愈的结直肠癌患者,均行内镜下支架置入作为手术桥接。观察队列总生存与同期比利时全部结直肠癌患者无显著差异(P=0.14),技术成功率94.8%,结论认为支架桥接不恶化生存结局。
要点
- 97例梗阻性可能可治愈结直肠癌患者行内镜支架桥接手术,技术成功率94.8%。
- 观察队列总生存与同期比利时全部结直肠癌患者无显著差异(P=0.14)。
- 有无穿孔患者腹膜转移发生率无显著差异(22.2% vs 15.2%,P=0.47)。
核心结论
- 梗阻性结直肠癌根治性治疗前结肠支架置入有效且未恶化生存结局,肯定了支架作为手术桥接的作用。
研究设计与样本
- 前瞻性研究纳入1998至2013年间比利时一家医院97例梗阻性但可能可治愈的结直肠癌患者,均行内镜下支架置入作为手术桥接,操作相关不良事件与长期随访数据为回顾性收集。
主要发现
- 观察队列总生存与同期比利时全部结直肠癌患者无显著差异(P=0.14)。
- 两组1年、5年、10年生存率相似(95.9% vs 79.0%;54.7% vs 51.2%;41.0% vs 35.6%)。
- 技术成功率为94.8%,73例患者未发生任何不良事件。
- 支架移位发生于9例患者,微穿孔和大穿孔见于14例患者,对生存无影响。
- 有无任何类型穿孔患者腹膜转移发生率无显著差异(22.2% vs 15.2%,P=0.47)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Self-expandable metal stents are used increasingly in the treatment of obstructing colorectal cancer (CRC). Although endoscopic colon stenting is widely accepted in palliation, disagreement exists about its role in a curative setting. This study aims to describe long-term survival data in a large patient group treated with colon stenting as a bridge to surgery for CRC. METHODS: This prospective study included 97 patients who presented in a Belgian hospital between 1998 and 2013 with obstructing, although potentially curable, CRC. All patients underwent endoscopic stenting as a bridge to surgery. Procedure-related adverse events and long-term follow-up data were retrospectively collected and compared with the CRC mortality in Belgium in the same time span. RESULTS: Overall survival in this observational cohort did not differ significantly from survival in all Belgian patients with CRC in the same period (P = .14). One-year, 5-year, and 10-year survival rates were similar in both groups (95.9% vs 79.0%; 54.7% vs 51.2%; 41.0% vs 35.6%, respectively). The technical success rate was 94.8%. Seventy-three patients did not experience any adverse event. Stent migration occurred in 9 patients, whereas micro-perforations and macro-perforations were observed in 14 patients, without influence on survival. Incidence rates of peritoneal metastases did not differ between patients with and without any type of perforation (22.2% vs 15.2%, respectively; P = .47). The type of stent influenced the overall adverse event risk, mainly driven by a significant increase in stent migration in case of Wallstent enteral (Boston Scientific Corporation, Natick, Mass). CONCLUSIONS: Colon stenting before surgery is effective and did not worsen the survival outcome in patients with obstructing CRC who were treated with curative intent, which affirms the role for stenting as a bridge to surgery.
引用
- Verstockt B, Van Driessche A, De Man M, et al. Ten-year survival after endoscopic stent placement as a bridge to surgery in obstructing colon cancer. Gastrointest Endosc. 2017. PMID: 28579348. doi:10.1016/j.gie.2017.05.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。